MedPath

The effect of vaginal Royal jelly and vaginal premarin on the quality of life of menopause women who referred to gynecology clinic of Hajar Hospital in Shahrekord

Phase 1
Conditions
Menopause.
Menopausal and female climacteric states
Registration Number
IRCT2014112220043N1
Lead Sponsor
Shahrekord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Menopausal women; aged between 50 to 65 years; married women; diagnosis of vaginal atrophy
Exclusion criteria: Diabetes mellitus; history of endometrial cancer; history of breast cancer; cystocele; hormone therapy; sensitivity to honey products or premarin

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: At the beginning and end of the study. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Vaginal atrophy. Timepoint: At the beginning and end of the study. Method of measurement: Pap-Smear test.
© Copyright 2025. All Rights Reserved by MedPath